PRRX2
Paired mesoderm homeobox protein 2
Also known as: PMX2, PRRX2_HUMAN, PRX2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99811
- Gene
- PRRX2
- Ensembl
- ENSG00000167157
- Chromosome
- 9
- Canonical length
- 253 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
The DNA-associated protein encoded by this gene is a member of the paired family of homeobox proteins. Expression is localized to proliferating fetal fibroblasts and the developing dermal layer, with downregulated expression in adult skin. Increases in expression of this gene during fetal but not adult wound healing suggest a possible role in mechanisms that control mammalian dermal regeneration and prevent formation of scar response to wounding. The expression patterns provide evidence consistent with a role in fetal skin development and a possible role in cellular proliferation. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
253 residues, UniProt reviewed canonical sequence.
>Q99811|PRRX2
1 MDSAAAAFAL DKPALGPGPP PPPPALGPGD CAQARKNFSV SHLLDLEEVA AAGRLAARPG
61 ARAEAREGAA REPSGGSSGS EAAPQDGECP SPGRGSAAKR KKKQRRNRTT FNSSQLQALE
121 RVFERTHYPD AFVREELARR VNLSEARVQV WFQNRRAKFR RNERAMLASR SASLLKSYSQ
181 EAAIEQPVAP RPTALSPDYL SWTASSPYST VPPYSPGSSG PATPGVNMAN SIASLRLKAK
241 EFSLHHSQVP TVNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRRX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 52 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 52 nTPM
- skin: 25 nTPM
- cervix: 20 nTPM
- vagina: 18 nTPM
- adipose tissue: 14 nTPM
- prostate: 13 nTPM
Single-cell type
- early spermatids: 91 nCPM
- fibroblasts: 77 nCPM
- endometrial secretory cells: 73 nCPM
- late primary spermatocytes: 45 nCPM
- vascular smooth muscle cells: 39 nCPM
- pericytes: 38 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 1.8 nTPM
- choroid plexus: 1.5 nTPM
- pons: 0.7 nTPM
- cerebral cortex: 0.6 nTPM
- hippocampal formation: 0.6 nTPM
- amygdala: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0.14
- gnomAD missense Z
- 0.48
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRRX2 as an antibody target. Whether an autoantibody or antibody against PRRX2 could matter depends on whether native PRRX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRRX2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRRX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...